UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 573

Sortiert nach

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

Journal of thrombosis and haemostasis, 2012-03, Vol.10 (3), p.359-367

2012

Volltextzugriff (PDF)

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience

BMC musculoskeletal disorders, 2022-12, Vol.23 (1), p.1111-1111, Article 1111

2022

Volltextzugriff (PDF)

Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.556-565

2017

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1788-1800

2014

Volltextzugriff (PDF)

PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.832-843

2017

Volltextzugriff (PDF)

Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.261-270

2018

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.104-112

2018

Volltextzugriff (PDF)

Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e870-e876

2011

Volltextzugriff (PDF)

Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.821-831

2017

Volltextzugriff (PDF)

Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.e196-e201

2011

Volltextzugriff (PDF)

Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.e77-e80

2018

Volltextzugriff (PDF)

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.392-399

2017

Volltextzugriff (PDF)

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.e39-e42

2017

Volltextzugriff (PDF)

The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience

Journal of thrombosis and haemostasis, 2011-11, Vol.9 (11), p.2229-2234

2011

Volltextzugriff (PDF)

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

The New England journal of medicine, 2022-03, Vol.386 (11), p.1013-1025

2022

Volltextzugriff (PDF)

How we treat: Haematuria in adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.683-685

2010

Volltextzugriff (PDF)

Emerging clinical concerns in the ageing haemophilia patient

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-11, Vol.15 (6), p.1197-1209

2009

Volltextzugriff (PDF)

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-11, Vol.18 (6), p.881-887

2012

Volltextzugriff (PDF)

Management of bleeding disorders in the elderly

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (s2), p.37-45

2012

Volltextzugriff (PDF)

1925P Results of SOC-2082 phase II study using metronomic gemcitabine, doxorubicin, and docetaxel plus nivolumab as second/third-line therapy for advanced leiomyosarcoma

Annals of oncology, 2023-10, Vol.34, p.S1035-S1035

2023

Volltextzugriff (PDF)

Inter- and intra-observer reliability of radiographic scores commonly used for the evaluation of haemophilic arthropathy

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.504-512

2008

Volltextzugriff (PDF)

Same day outpatient transjugular liver biopsies in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-11, Vol.10 (6), p.727-731

2004

Volltextzugriff (PDF)

Formation of β -amyloid protein deposits in brains of transgenic mice

Nature (London), 1991-07, Vol.352 (6332), p.239-241

1991

Volltextzugriff (PDF)

PB0630 Final Analysis of Long-Term Clinical Outcomes of Prophylaxis with a Recombinant Factor VIII Fc Fusion Protein in Adults Aged ≥50 Years with Severe Hemophilia A

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101200, Article 101200

2023

Volltextzugriff (PDF)

1 – 25 von 573

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(536)
Mit Volltextzugriff
(500)

Publikationsform

Sprache

Englisch
(573)
Japanisch
(69)

Erscheinungsjahr

n.n

Thema

Science & Technology
(364)
Life Sciences & Biomedicine
(299)
Humans
(245)
Male
(147)
Female
(113)
Middle Aged
(79)
Animals
(75)
Biological And Medical Sciences
(70)
Oncology
(70)
Adult
(67)
Aged
(61)
Technology
(53)
Medical Sciences
(50)
Retrospective Studies
(45)
Radiology, Nuclear Medicine & Medical Imaging
(44)
Surgery
(44)
Biochemistry & Molecular Biology
(34)
Engineering
(34)
Mice
(34)
Hematology, Oncology And Palliative Medicine
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience

Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding

Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis

Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices

Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis

Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

How we treat: Haematuria in adults with haemophilia

Emerging clinical concerns in the ageing haemophilia patient

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Management of bleeding disorders in the elderly

1925P Results of SOC-2082 phase II study using metronomic gemcitabine, doxorubicin, and docetaxel plus nivolumab as second/third-line therapy for advanced leiomyosarcoma

Inter- and intra-observer reliability of radiographic scores commonly used for the evaluation of haemophilic arthropathy

Same day outpatient transjugular liver biopsies in haemophilia

Formation of β -amyloid protein deposits in brains of transgenic mice

PB0630 Final Analysis of Long-Term Clinical Outcomes of Prophylaxis with a Recombinant Factor VIII Fc Fusion Protein in Adults Aged ≥50 Years with Severe Hemophilia A

Suchergebnisse filtern